Headache & Pain

Filter Your Results

 

News

 

Dystonia and Spasticity Patients May Become Immune to Toxin Treatment

Tuesday, December 04, 2018—People with dystonia or spasticity can get relief from botulinum toxin type A, but a new study published online in Neurology shows that 15% of people treated with th…

Biases in Dementia Screening Tools

Wednesday, November 28, 2018—Brief cognitive tests are useful screening tools for dementia in the primary care setting; however, a study published in the journal Neurology Clinical Practice show…

First Patient Enrolled in Study of Oral CGRP Receptor Antagonist for Migraine

Tuesday, November 20, 2018—The first patient is enrolled in a phase 3 trial for the oral calcitonin gene-related peptide (CGRP) receptor antagonist rimegepant (Biohaven; New Haven, CT). The trial will a…

New Drug Application for Migraine Headache Therapy Lasmitidan

Monday, November 19, 2018—A New Drug Application (NDA) for lasmiditan (Eli Lilly and Company, Indianapolis, IN) has been submitted to the Food and Drug Administration (FDA). Lasmitidan is an investigat…

Migraines that Affect Vision May Increase Risk of Atrial Fibrillation

Thursday, November 15, 2018—People who experience migraine with visual aura may have an increased risk of atrial fibrillation (AFib), according to a study published in Neurology.  Participan…

Study Confirms Benefits of Laser Interstitial Thermal Therapy

Wednesday, November 14, 2018—A prospective, multi-center clinical study of 42 patients with brain lesions that recurred after stereotactic radiosurgery (SRS) for metastatic brain tumors showed p…

Personal Pain Management App Approved for Use with Intrathecal Drug Delivery Pump

Wednesday, October 24, 2018—The US Food and Drug Administration (FDA) has approved use of an application (myPTM Personal Therapy Manager; Medtronic, Dublin, Ireland) for patients with chronic pain to use…

First Patient Treated in Trial of BHV-3500—A Nasally Delivered CGRP-Receptor Antagonist Being Investigated for Migraine

Tuesday, October 23, 2018—The first participant has been treated in a clinical trial of BHV-3500 (Biohaven, New Haven, CT) for the treatment of patients with migraine. The first intranasal formulation …

 
 

Contact Info

For advertising rates and opportunities:
Wendy Terry
Publisher
217-652-3859
wterry@bmctoday.com

About Practical Neurology

Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.

 
  • BRYN MAWR COMMUNICATIONS III, LLC